MPO gene

Last updated on: 03.11.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The MPO gene (MPO stands for: myeloperoxidase) is a protein-coding gene located on chromosome 17q22.

Diseases associated with MPO include:

  • myeloperoxidase deficiency
  • and
  • Alzheimer's disease, familial
  • MPO mutations, especially those leading to complete MPO deficiency, are cumulatively associated with GPP (generalized pustular psoriasis) (Haskamp S et al. 2020). The activity of four proteases previously thought to be activating enzymes of IL-36 precursors correlated with MPO deficiency. MPO and the affected signaling pathways could represent attractive targets for the resolution of inflammation in neutrophils (Haskamp S et al. 2020).

General informationThis section has been translated automatically.

Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation and is the major component of neutrophil azurophil granules. Myeloperoxidase is produced as a single-chain precursor and is subsequently cleaved into a light chain and a heavy chain. Mature myeloperoxidase is a tetramer consisting of 2 light and 2 heavy chains. This enzyme produces acids that are central to the microbicidal activity of neutrophils. Thus, myeloperoxidase is part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In stimulated polymorphonuclear leukocytes, MPO catalyzes the production of hypochlorous acid (hypochlorous acid (HOCl) is a mild acid naturally produced in the white blood cells of all mammals. It plays an important role in our immune system e.g. in incipient infections) which significantly increases the microbicidal activity of polymorphonuclear leukocytes. Mediates proteolytic cleavage of alpha-1 microglobulin to form t-alpha-1 microglobulin, which effectively inhibits oxidation of low-density lipoprotein particles and limits vascular damage.

LiteratureThis section has been translated automatically.

  1. Cech P et al (1979) Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med 66: 149-153
  2. Cramer R et al (1982) Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Brit J Haemat 51: 81-87
  3. DeLeo FR et al (1998) A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation. J Clin Invest 101: 2900-2909.
  4. Fujisawa T et al (2015) Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis: Therapeutic Outcomes in Three Refractory Patients. Ther Apher Dial 19:336-341.
  5. Haskamp S et al (2020) Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases. Am J Hum Genet 107:527-538. d

  6. Mizutani Y et al (2020) Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. J Dermatol 47:1326-1329.
  7. Takeichi T et al. (2023) Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis. Exp Dermatol 32:1557-1562.

Last updated on: 03.11.2023